Psychological Symptoms and Physical Limitations With Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is a genetic disease of myocytes caused by a mutation in genes encoding for sarcomere proteins resulting in alterations in cardiac structure, hence affecting its function.1 It is believed that most deaths in patients living with HCM are cardiac –related, with 16% be...
Gespeichert in:
| Veröffentlicht in: | The American journal of cardiology 2022-07, Vol.174, p.179-180 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 180 |
|---|---|
| container_issue | |
| container_start_page | 179 |
| container_title | The American journal of cardiology |
| container_volume | 174 |
| creator | Asbeutah, Abdul Aziz A. Ingram, Eva Mouksian, Kristina Wilbanks, David Alexander, John Bath, Anandbir Salberg, Lisa Jefferies, John L. |
| description | Hypertrophic cardiomyopathy (HCM) is a genetic disease of myocytes caused by a mutation in genes encoding for sarcomere proteins resulting in alterations in cardiac structure, hence affecting its function.1 It is believed that most deaths in patients living with HCM are cardiac –related, with 16% being sudden cardiac death (SCD).2 HCM is a chronic condition that creates physical limitations and affects the psychological and emotional well-being of patients. A recent study in China concluded that depression in patients with HCM was independently associated with an increased risk of SCD and heart failure events.3 Hence, we aimed to estimate the prevalence of anxiety and depression-related symptoms and physical limitations in adults living with HCM and implantable cardioverter-defibrillators (ICDs) in the United States. [...]incorporating a multidisciplinary approach by including psychologists and social workers early to assist and identify the psychological and social needs of patients with HCM is imperative. |
| doi_str_mv | 10.1016/j.amjcard.2022.03.031 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2659606094</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914922003484</els_id><sourcerecordid>2669517389</sourcerecordid><originalsourceid>FETCH-LOGICAL-c341t-49aec7f1366de92443a4da92e4e961f252203b2f9771c0e2bb1dfa84d6923dbe3</originalsourceid><addsrcrecordid>eNqFkN-L1DAQgIMo3nr6JygFX3zpmknSdPMksniesODCnfgY0mRqU9qmJl2h_72529UHX4SBYYZvfvAR8hroFijI9_3WjL010W0ZZWxLeQ54Qjawq1UJCvhTsqGUslKBUFfkRUp9LgEq-Zxc8aqiohZyQ47HtNouDOGHt2Yo7tZxXsKYCjO54tit6bF78KNfzOLDlIrvfumK23XGuMQwd94W-_yED-MaZrN060vyrDVDwleXfE2-3Xy639-Wh6-fv-w_HkrLBSylUAZt3QKX0qFiQnAjnFEMBSoJLasYo7xhraprsBRZ04BrzU44qRh3DfJr8u68d47h5wnTokefLA6DmTCckmayUpJKqkRG3_6D9uEUp_xdpqSqoOY7lanqTNkYUorY6jn60cRVA9UPynWvL8r1g3JNeQ7Ic28u20_NiO7v1B_HGfhwBjDr-OUx6mQ9Thadj2gX7YL_z4nfb9aVDw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2669517389</pqid></control><display><type>article</type><title>Psychological Symptoms and Physical Limitations With Hypertrophic Cardiomyopathy</title><source>Elsevier ScienceDirect Journals</source><creator>Asbeutah, Abdul Aziz A. ; Ingram, Eva ; Mouksian, Kristina ; Wilbanks, David ; Alexander, John ; Bath, Anandbir ; Salberg, Lisa ; Jefferies, John L.</creator><creatorcontrib>Asbeutah, Abdul Aziz A. ; Ingram, Eva ; Mouksian, Kristina ; Wilbanks, David ; Alexander, John ; Bath, Anandbir ; Salberg, Lisa ; Jefferies, John L.</creatorcontrib><description>Hypertrophic cardiomyopathy (HCM) is a genetic disease of myocytes caused by a mutation in genes encoding for sarcomere proteins resulting in alterations in cardiac structure, hence affecting its function.1 It is believed that most deaths in patients living with HCM are cardiac –related, with 16% being sudden cardiac death (SCD).2 HCM is a chronic condition that creates physical limitations and affects the psychological and emotional well-being of patients. A recent study in China concluded that depression in patients with HCM was independently associated with an increased risk of SCD and heart failure events.3 Hence, we aimed to estimate the prevalence of anxiety and depression-related symptoms and physical limitations in adults living with HCM and implantable cardioverter-defibrillators (ICDs) in the United States. [...]incorporating a multidisciplinary approach by including psychologists and social workers early to assist and identify the psychological and social needs of patients with HCM is imperative.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2022.03.031</identifier><identifier>PMID: 35504746</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Anxiety ; Cardiomyopathy ; Congestive heart failure ; COVID-19 ; Defibrillators ; Genetic disorders ; Mental depression ; Mutation ; Myocytes ; Quality of life ; Signs and symptoms</subject><ispartof>The American journal of cardiology, 2022-07, Vol.174, p.179-180</ispartof><rights>2022 Elsevier Inc.</rights><rights>2022. Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c341t-49aec7f1366de92443a4da92e4e961f252203b2f9771c0e2bb1dfa84d6923dbe3</cites><orcidid>0000-0001-7980-2580 ; 0000-0002-4046-2352</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002914922003484$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35504746$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Asbeutah, Abdul Aziz A.</creatorcontrib><creatorcontrib>Ingram, Eva</creatorcontrib><creatorcontrib>Mouksian, Kristina</creatorcontrib><creatorcontrib>Wilbanks, David</creatorcontrib><creatorcontrib>Alexander, John</creatorcontrib><creatorcontrib>Bath, Anandbir</creatorcontrib><creatorcontrib>Salberg, Lisa</creatorcontrib><creatorcontrib>Jefferies, John L.</creatorcontrib><title>Psychological Symptoms and Physical Limitations With Hypertrophic Cardiomyopathy</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Hypertrophic cardiomyopathy (HCM) is a genetic disease of myocytes caused by a mutation in genes encoding for sarcomere proteins resulting in alterations in cardiac structure, hence affecting its function.1 It is believed that most deaths in patients living with HCM are cardiac –related, with 16% being sudden cardiac death (SCD).2 HCM is a chronic condition that creates physical limitations and affects the psychological and emotional well-being of patients. A recent study in China concluded that depression in patients with HCM was independently associated with an increased risk of SCD and heart failure events.3 Hence, we aimed to estimate the prevalence of anxiety and depression-related symptoms and physical limitations in adults living with HCM and implantable cardioverter-defibrillators (ICDs) in the United States. [...]incorporating a multidisciplinary approach by including psychologists and social workers early to assist and identify the psychological and social needs of patients with HCM is imperative.</description><subject>Anxiety</subject><subject>Cardiomyopathy</subject><subject>Congestive heart failure</subject><subject>COVID-19</subject><subject>Defibrillators</subject><subject>Genetic disorders</subject><subject>Mental depression</subject><subject>Mutation</subject><subject>Myocytes</subject><subject>Quality of life</subject><subject>Signs and symptoms</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkN-L1DAQgIMo3nr6JygFX3zpmknSdPMksniesODCnfgY0mRqU9qmJl2h_72529UHX4SBYYZvfvAR8hroFijI9_3WjL010W0ZZWxLeQ54Qjawq1UJCvhTsqGUslKBUFfkRUp9LgEq-Zxc8aqiohZyQ47HtNouDOGHt2Yo7tZxXsKYCjO54tit6bF78KNfzOLDlIrvfumK23XGuMQwd94W-_yED-MaZrN060vyrDVDwleXfE2-3Xy639-Wh6-fv-w_HkrLBSylUAZt3QKX0qFiQnAjnFEMBSoJLasYo7xhraprsBRZ04BrzU44qRh3DfJr8u68d47h5wnTokefLA6DmTCckmayUpJKqkRG3_6D9uEUp_xdpqSqoOY7lanqTNkYUorY6jn60cRVA9UPynWvL8r1g3JNeQ7Ic28u20_NiO7v1B_HGfhwBjDr-OUx6mQ9Thadj2gX7YL_z4nfb9aVDw</recordid><startdate>20220701</startdate><enddate>20220701</enddate><creator>Asbeutah, Abdul Aziz A.</creator><creator>Ingram, Eva</creator><creator>Mouksian, Kristina</creator><creator>Wilbanks, David</creator><creator>Alexander, John</creator><creator>Bath, Anandbir</creator><creator>Salberg, Lisa</creator><creator>Jefferies, John L.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7980-2580</orcidid><orcidid>https://orcid.org/0000-0002-4046-2352</orcidid></search><sort><creationdate>20220701</creationdate><title>Psychological Symptoms and Physical Limitations With Hypertrophic Cardiomyopathy</title><author>Asbeutah, Abdul Aziz A. ; Ingram, Eva ; Mouksian, Kristina ; Wilbanks, David ; Alexander, John ; Bath, Anandbir ; Salberg, Lisa ; Jefferies, John L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c341t-49aec7f1366de92443a4da92e4e961f252203b2f9771c0e2bb1dfa84d6923dbe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anxiety</topic><topic>Cardiomyopathy</topic><topic>Congestive heart failure</topic><topic>COVID-19</topic><topic>Defibrillators</topic><topic>Genetic disorders</topic><topic>Mental depression</topic><topic>Mutation</topic><topic>Myocytes</topic><topic>Quality of life</topic><topic>Signs and symptoms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Asbeutah, Abdul Aziz A.</creatorcontrib><creatorcontrib>Ingram, Eva</creatorcontrib><creatorcontrib>Mouksian, Kristina</creatorcontrib><creatorcontrib>Wilbanks, David</creatorcontrib><creatorcontrib>Alexander, John</creatorcontrib><creatorcontrib>Bath, Anandbir</creatorcontrib><creatorcontrib>Salberg, Lisa</creatorcontrib><creatorcontrib>Jefferies, John L.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Asbeutah, Abdul Aziz A.</au><au>Ingram, Eva</au><au>Mouksian, Kristina</au><au>Wilbanks, David</au><au>Alexander, John</au><au>Bath, Anandbir</au><au>Salberg, Lisa</au><au>Jefferies, John L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Psychological Symptoms and Physical Limitations With Hypertrophic Cardiomyopathy</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2022-07-01</date><risdate>2022</risdate><volume>174</volume><spage>179</spage><epage>180</epage><pages>179-180</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><abstract>Hypertrophic cardiomyopathy (HCM) is a genetic disease of myocytes caused by a mutation in genes encoding for sarcomere proteins resulting in alterations in cardiac structure, hence affecting its function.1 It is believed that most deaths in patients living with HCM are cardiac –related, with 16% being sudden cardiac death (SCD).2 HCM is a chronic condition that creates physical limitations and affects the psychological and emotional well-being of patients. A recent study in China concluded that depression in patients with HCM was independently associated with an increased risk of SCD and heart failure events.3 Hence, we aimed to estimate the prevalence of anxiety and depression-related symptoms and physical limitations in adults living with HCM and implantable cardioverter-defibrillators (ICDs) in the United States. [...]incorporating a multidisciplinary approach by including psychologists and social workers early to assist and identify the psychological and social needs of patients with HCM is imperative.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>35504746</pmid><doi>10.1016/j.amjcard.2022.03.031</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-7980-2580</orcidid><orcidid>https://orcid.org/0000-0002-4046-2352</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9149 |
| ispartof | The American journal of cardiology, 2022-07, Vol.174, p.179-180 |
| issn | 0002-9149 1879-1913 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2659606094 |
| source | Elsevier ScienceDirect Journals |
| subjects | Anxiety Cardiomyopathy Congestive heart failure COVID-19 Defibrillators Genetic disorders Mental depression Mutation Myocytes Quality of life Signs and symptoms |
| title | Psychological Symptoms and Physical Limitations With Hypertrophic Cardiomyopathy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T12%3A06%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Psychological%20Symptoms%20and%20Physical%20Limitations%20With%20Hypertrophic%20Cardiomyopathy&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Asbeutah,%20Abdul%20Aziz%20A.&rft.date=2022-07-01&rft.volume=174&rft.spage=179&rft.epage=180&rft.pages=179-180&rft.issn=0002-9149&rft.eissn=1879-1913&rft_id=info:doi/10.1016/j.amjcard.2022.03.031&rft_dat=%3Cproquest_cross%3E2669517389%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2669517389&rft_id=info:pmid/35504746&rft_els_id=S0002914922003484&rfr_iscdi=true |